NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
2.50
-1.38%
After-hours: Aug 15, 2025, 06:36 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.17M -16.5M -11.95M
Depreciation & Amortization
11.41K 11.41K 10.05K
Stock-Based Compensation
164.91K 22.73K n/a
Other Working Capital
-8.54K 990.55K -875.26K
Other Non-Cash Items
59.53K 364.64K 166.51K
Deferred Income Tax
n/a 613.42K n/a
Change in Working Capital
2.25M 1.63M -3.17M
Operating Cash Flow
-9.68M -13.88M -14.94M
Capital Expenditures
-4 n/a -39.56K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a -3.51M -39.56K
Debt Repayment
1.63M 825.84K -2.1M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 7.35M 7.89M
Financial Cash Flow
1.63M 17.4M 20.34M
Net Cash Flow
-8.05M 3.52M 5.34M
Free Cash Flow
-9.68M -13.88M -14.98M